View Document Preview and Link Document Date: 2012-11-27 17:11:26 Open Document File Size: 140,61 KB Share Result on Facebook
Company HIV The NDDoH / / Country United States / / Currency STD / USD / / / Event M&A / FDA Phase / / Facility Laboratory Services / / IndustryTerm prevention of HIV / CDC's Sexually Transmitted Diseases Treatment / HIV Prevention / partner services / treatment of HIV / treatment for HIV / / MedicalCondition Gonococcal Infections / TB / HIV / newly acquired HIV infection / acute bloodborne infection / hepatitis C / HIV infections / injury / culture-based gonorrhea / antibiotic-resistant infections / liver cirrhosis / Hepatitis / HCV infections / liver disease / infections / HIV infection / ia/gonorrhea / disease / chlamydia/gonorrhea / hepatocellular carcinoma / updated gonorrhea / HCV / gonorrhea infections / HCV infection / HIV/STD/Hepatitis / AIDS / infection / chlamydia/ gonorrhea / gonorrhea / / MedicalTreatment counseling / hemodialysis / / Organization NDDoH Division of Laboratory Services / American Red Cross / Division of Disease Control / Division of Laboratory Services / Heartview Foundation / FDA / Department of Health / / Person Shannon Jahner / Kent Martin / Sarah Weninger / Christopher Wegner / / / Position STD Surveillance Coordinator / gram manager / / Product Truvada / doxycycline / Complera / ceftriaxone / Complera Fargo / / ProvinceOrState North Dakota / / Region Eastern North Dakota / / Technology antibodies / / URL www.medscape.org / www.cdc.gov / www.cdc.gov/std/gisp / www.ndhealth.gov/STD / / SocialTag 
HIV/STD/Hepatitis/TB Newsletter Volume 1, Issue 3 Fall/Winter 2012